Jordan
Department of Pharmaceutics and Pharmaceutical technology, Faculty of Pharmacy, Irbid
Dr. Alaa Aljabali is a renowned professor in nanotechnology with a PhD in bionanotechnology from John Innes Centre. Her research interests lie at the intersection of material sciences, pharmacy, physics, biology, and chemistry, with a focus on developing cutting-edge selective drug delivery systems. Dr. Aljabali has made significant contributions to the field of drug delivery, drug targeting, and protein nanotechnology.
Throughout her career, Dr. Aljabali has been dedicated to designing and developing innovative drug delivery systems that can target specific tissues and cells with minimal side effects. She has been actively involved in research projects that explore the use of nanotechnology for drug delivery, including the design of nanoparticles and liposomes that can effectively deliver drugs to target sites. Dr. Aljabali ‘s work has also focused on developing protein-based drug delivery systems that can selectively target cancer cells.
Dr. Aljabali ‘s research has been widely recognized for its impact on the field of drug delivery. She has published numerous articles in top-tier scientific journals and has been invited to present her research at conferences and symposia around the world. In addition to her research, Dr. Aljabali is also an enthusiastic mentor, and many of her former students have gone on to successful careers in academia and industry.
Overall, Dr. Alaa Aljabali is a respected figure in the field of nanotechnology and drug delivery. Her research has the potential to transform the way we think about drug delivery, and her innovative ideas and insights continue to drive the field forward.